VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $9,673,000 | -25.2% | 607,618 | -2.3% | 2.68% | -24.8% |
Q4 2017 | $12,928,000 | +43.4% | 622,146 | -1.1% | 3.57% | +40.8% |
Q3 2017 | $9,013,000 | -17.8% | 629,003 | -0.8% | 2.54% | -16.1% |
Q2 2017 | $10,964,000 | +54.9% | 633,787 | -1.2% | 3.02% | +56.8% |
Q1 2017 | $7,078,000 | -9.2% | 641,738 | +19.5% | 1.93% | -9.1% |
Q4 2016 | $7,795,000 | -51.1% | 536,894 | -17.4% | 2.12% | -50.0% |
Q3 2016 | $15,956,000 | +13.3% | 649,959 | +13.4% | 4.24% | +17.3% |
Q2 2016 | $14,086,000 | +103.2% | 573,321 | +117.5% | 3.62% | +115.4% |
Q1 2016 | $6,933,000 | -2.4% | 263,641 | +277.3% | 1.68% | +4.3% |
Q4 2015 | $7,102,000 | – | 69,874 | – | 1.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |